Sumitomo Pharma Co., Ltd. (4506) Balance sheet

Market cap

¥581.7B

P/E ratio

8.5x

Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	30,553	54,922	71,408	79,201	137,296	101,708	193,698	202,984	143,478	29,047	23,116	44,310
Marketable securities, current	-	111,293	81,039	34,195	2,000	43,750	28,717	29,480	35,596	20,174	7,085	16,840	5,327
Accounts receivable, net	-	103,072	107,165	110,932	112,982	118,760	134,491	135,866	151,407	95,908	81,023	74,840	131,414
Inventories	-	50,749	48,100	54,973	34,190	66,889	79,368	92,215	99,021	94,405	115,350	94,222	85,414
Total current assets	-	401,699	421,584	376,454	271,187	373,268	364,090	459,795	499,521	381,860	269,569	253,168	279,252
Property, plant and equipment, net	-	65,160	61,824	59,253	46,837	59,485	65,748	64,966	64,091	58,909	57,895	46,648	44,231
Marketable securities, non-current	-	58,193	60,432	48,034	59,846	74,668	200,923	193,035	115,844	134,007	161,711	44,148	44,703
Total non-current assets	-	309,884	286,130	417,495	409,214	461,449	888,788	848,332	808,486	752,882	637,937	489,436	525,319
Total assets	-	711,583	707,715	793,950	809,684	834,717	1,252,878	1,308,127	1,308,007	1,134,742	907,506	742,604	804,571
Accounts payable	-	12,492	12,153	14,514	58,708	49,238	62,251	64,638	46,183	52,141	67,720	38,544	56,698
Short-term debt	-	-	1,010	40,000	3,500	8,673	272,960	23,341	25,085	90,588	285,517	46,440	38,130
Long-term debt, current	-	6,522	12,000	8,000	2,960	2,960	2,960	4,960	20,060	-	60,000	4,000	-
Total current liabilities	-	156,843	179,722	228,447	68,761	198,174	496,498	278,147	278,373	372,694	515,474	240,603	271,500
Long-term debt, non-current	-	-	-	-	119,367	108,367	66,326	285,263	260,434	255,997	146,105	274,800	195,619
Total non-current liabilities	-	103,718	81,520	104,846	50,531	138,405	124,275	381,802	356,065	355,266	235,896	332,522	240,604
Total liabilities	-	260,562	261,242	333,293	356,961	336,579	620,773	659,949	634,438	727,960	751,370	573,125	512,104
Retained earnings	-	326,686	341,401	363,627	494,447	431,799	457,330	508,677	514,210	280,999	-22,665	46,784	158,981
Stockholders' equity	398,540	451,021	446,472	460,656	561,109	498,138	632,105	648,178	673,569	406,782	156,136	169,479	273,824
Working capital	-